Page 163 - Read Online

Purkait et al. Vessel Plus 2018;2:19 I http://dx.doi.org/10.20517/2574-1209.2018.16 Page 9 of 10

28. Chiang FT, Hsu KL, Tseng CD, Lo HM, Chern TH, Tseng YZ. Association of the renin gene polymorphism with essential hypertension
in a Chinese population. Clin Genet 1997;51:370-4.
29. Sarkar S, Gupta V, Kumar A, Chaudhary M, Diyundi S, Sehajpal PK, Thangaraj K, Rajender S. M235T polymorphism in the AGT gene
and A/GI8-83 substitution in the REN gene correlate with end-stage renal disease. Nephron 2015;129:104-8.
30. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res
1988;16:1215.
31. Purkait P, Halder K, Thakur S, Ghosh Roy A, Raychaudhuri P, Bhattacharya S, Sarkar BN, Naidu JM. Association of angiotensinogen
gene SNPs and haplotypes with risk of hypertension in eastern Indian population. Clin Hypertens 2017;23:12.
32. Purkait P, Roy AG, Halder K, Suthar P, Raychaudhuri P, Bhattacharya S, Sarkar BN, Naidu JM. Sex-based association of CYP11B2 (-344
C/T) polymorphism in Indian type 2 diabetic patients. Int J Diabetol Vasc Dis Res 2015;3:89-93.
33. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a
toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007;81:559-75.
34. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
35. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero
SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. The structure of haplotype blocks in the human
genome. Science 2002;296:2225-9.
36. Frossard PM, Gonzalez PA, Fritz LC, Ponte PA, Fiddes JC, Atlas SA. Two RFLPs at the human renin (ren) gene locus. Nucleic Acids
Res 1986;14:4380.
37. Frossard PM, Lestringant GG, Malloy MJ, Kane JP. Human renin gene BglI dimorphism associated with hypertension in two
independent populations. Clin Genet 1999;56:428-33.
38. Naftilan AJ, Williams R, Burt D, Paul M, Pratt RE, Hobart P, Chirgwin J, Dzau VJ. A lack of genetic linkage of renin gene restriction
fragment length polymorphisms with human hypertension. Hypertension 1989;14:614-8.
39. Deinum J, Tarnow L, van Gool JM, de Bruin RA, Derkx FH, Schalekamp MA, Parving HH. Plasma renin and prorenin and renin gene
variation in patients with insulin-dependent diabetes mellitus and nephropathy. Nephrol Dial Transplant 1999;14:1904-11.
40. Hasegawa G, Nakano K, Sawada M, Uno K, Shibayama Y, Ienaga K, Kondo M. Possible role of tumor necrosis factor and interleukin-1
in the development of diabetic nephropathy. Kidney Int 1991;40:1007-12.
41. Heesom AE, Hibberd ML, Millward A, Demaine AG. Polymorphism in the 5’-end of the aldose reductase gene is strongly associated
with the development of diabetic nephropathy in type1 diabetes. Diabetes 1997;46:287-91.
42. Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P; Irbesartan in Patients with Type 2 Diabetes and
Microalbuminuria Study Group. The effect of irbesartanon the development of diabetic nephropathy in patient with type 2 diabetes. N
Engl J Med 2001;345:870-8.
43. Purkait P, Halder K, Roy AG, Sarkar BN, Naidu JM. GSTM1 null genotype associated with type 2 diabetic nephropathy patients among
Indian population. World J Pharm Res 2014;3:4452-63.
44. Hasimu B, Nakayama T, Mizutani Y, Izumi Y, Asai S, Soma M, Kokubun S, Ozawa Y. Haplotype analysis of the human renin gene and
essential hypertension. Hypertension 2003;41:308-12.
45. Viswanathan V. Prevention of diabetic nephropathy: a diabetologist’s perspective. Indian J Nephrol 2004;14:157-62.
46. O’Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. Evidence for association and
genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the
Framingham Heart Study. Circulation 1998;97:1766-72.
47. Manrique C, Lastra G, Gardner M, Sowers JR. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and
oxidative stress. Med Clin North Am 2009;93:569-82.
48. Lin J, Hu FB, Qi L and Curhan GC. Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal
dysfunction and coronary heart disease in type 2 diabetes mellitus. BMC Nephrol 2009;10:9.
49. Chang HR, Cheng CH, Shu KH, Chen CH, Lian JD, Wu MY. Study of the polymorphism of angiotensinogen, anigiotensin-converting
enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan. J Chin Med Assoc 2003;66:51-6.
50. Ezzidi I, Mtiraoui N, Kacem M, Chaieb M, Mahjoub T, Almawi WY. Identification of specific angiotensin-converting enzyme variants
and haplotypes that confer risk and protection against type 2 diabetic nephropathy. Diabetes Metab Res Rev 2009;25:717-24.
51. van Ittersum FJ, de Man AM, Thijssen S, de Knijff P, Slagboom E, Smulders Y, Tarnow L, Donker AJ, Bilo HJ, Stehouwer CD. Genetic
polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant
2000;15:1000-7.
52. Mitchell KD, Navar LG. Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension, in hypertension:
pathophysiology, diagnosis and management. In: Laragh JH, Brenner BM, editors. New York: Raven Press; 1995. p. 1437-50.
53. Navar LG, Prieto-Carrasquero MC, Kobori H. Renal renin-angiotensin system. In: Kastin AJ, editor. Handbook of Biologically Active
Peptides. Academic Press; 2006. p. 1235-42.
54. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of
hypertension and kidney disease. Pharmacol Rev 2007;59:251-87.
55. Ingert C, Grima M, Coquard C, Barthelmebs M, Imbs JL. Contribution of angiotensin II internalization to intrarenal angiotensin II
levels in rats. Am J Physiol Renal Physiol 2002;283:F1003-10.
56. Rosivall L, Navar LG. Effects on renal hemodynamics of intra-arterial infusions of angiotensins I and II. Am J Physiol 1983;245:F181-7.
57. Komlosi P, Fuson AL, Fintha A, Peti-Peterdi J, Rosivall L, Warnock DG, Bell PD. Angiotensin I conversion to angiotensin II stimulates